Stockreport

Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bi [Read more]